Economic Analysis Supporting Significant Hospitalization
Data illustrate the potential of QUELIMMUNE™️ with cost neutrality starting at 6 days of therapy and a significant reduction in...
Data illustrate the potential of QUELIMMUNE™️ with cost neutrality starting at 6 days of therapy and a significant reduction in...
CVAC System (Photo: Business Wire)CVAC System ProcedureMulti-Center ASPIRE 1-Year Study Results Show Healthcare Consumption Events are Significantly Lower after SURE...
Classified in: Health, Science and technologySubject: MRR Growing prevalence of blood disorders and chronic diseases drives demand for coagulation testing. ...